AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients - Concepedia

Concepedia

Publication | Open Access

AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients

DOI Full Paper Access

1.8K

Citations

40

References

2007

Year

Tracy T. Batchelor, A. Gregory Sorensen, Emmanuelle di Tomaso, Wei-Ting Zhang, Dan G. Duda, Kenneth S. Cohen, Kevin R. Kozak, Daniel P. Cahill, Poe-Jou Chen, Mingwang Zhu,

Normalizes Tumor VasculatureNeuro-oncologyNovel TherapyMedicinePharmacologyPathologyAlleviates EdemaGlioblastoma PatientsHigh-grade GliomasCancer TreatmentTumor SuppressorOncologyGliomaTumor MicroenvironmentTumor Biology

References

	Year	Citations

Page 1

Page 1